DNX Biopharmaceuticals — Form D

DNX Biopharmaceuticals of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-01. The offering totals $5.0M. Industry: Biotechnology.

Offering

• Filed: 2016-07-01
• Form: D
• Accession: 0001678670-16-000001
• Industry: Biotechnology
• Exemptions: 06c
• Total offering: $5.0M
• Remaining: $5.0M
• Minimum investment: $10K
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-266229

Issuer

• Name: DNX Biopharmaceuticals
• CIK: 0001678670
• Entity type: Corporation
• Jurisdiction: CALIFORNIA
• Address: 4225 EXECUTIVE SQUARE, SUITE 495, SAN DIEGO, CA, 92037
• Phone: 949-351-0860

Officers, directors & promoters (1)

More

• CIK 1678670 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search